Global Head and Neck Cancer Disease Analysis 2017-2026: Forecasts, Treatment, Marketed Drugs & Pipeline

Head and neck cancer is the sixth most common cancer worldwide, and includes malignancies that can originate in the oral cavity, salivary glands, sinuses, and throat. Around 90% of cases have an epithelial origin, which present as squamous cell carcinomas. Environmental factors such as tobacco smoking and alcohol consumption greatly increase the risk of developing head and neck cancers. If diagnosed at an early stage, treatment for these cancers can be curative; however, the majority of patients are diagnosed when the disease is advanced, resulting in the need for more than one treatment modality.

Head and neck cancer is the sixth most common cancer worldwide, and includes malignancies that can originate in the oral cavity, salivary glands, sinuses, and throat. Around 90% of cases have an epithelial origin, which present as squamous cell carcinomas. Environmental factors such as tobacco smoking and alcohol consumption greatly increase the risk of developing head and neck cancers. If diagnosed at an early stage, treatment for these cancers can be curative; however, the majority of patients are diagnosed when the disease is advanced, resulting in the need for more than one treatment modality.

Market Snapshot

Key Topics Covered:

Forecast: Head And Neck Cancer (Published On 01 December 2017)

Treatment: Head And Neck Cancer (Published On 15 September 2017)

Epidemiology: Head And Neck Cancer (Published On 08 August 2017)

Marketed Drugs: Head And Neck Cancer (Published On 01 December 2017)

Pipeline: Head And Neck Cancer (Published On 01 December 2017)

For more information about this report visit https://www.researchandmarkets.com/research/z49sf7/global_head_and?w=5

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716